From: Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial
Group
Eradication rate
P
H(K)
ITT
V1
38/45 (84.4%)
1.000
0.000
V2
V3
PP
38/43 (88.4%)
0.757
0.557
38/41 (92.7%)